BMA Science and Education department and the Board of Science.. (2013) Drugs of dependence: The role of medical professionals. London: British Medical Association.
Preview | Title | Contact |
---|---|---|
|
PDF (Drugs of dependence: the role of medical professionals)
- Submitted Version
1MB |
External website: http://bma.org.uk/news-views-analysis/in-depth-dru...
Executive summary
• Chapter 1 - Introduction
• Chapter 2 - The scale of the problem: illicit drug use in the UK
• Chapter 3 - The burden of illicit drug use
• Chapter 4 - Influences on illicit drug use
• Chapter 5 - Drug policy in the UK: from the 19th century to the present day
• Chapter 6 - Controlling illicit drug use
• Chapter 7 - Delaying initiation and minimising the use of illicit drugs
• Chapter 8 - Medical management of drug dependence: the doctor's role in managing heroin addiction
• Chapter 9 - Medical management of drug dependence: reducing secondary health harms
• Chapter 10 - Medical management of drug dependence in the context of criminal justice: illicit drug use, courts and prison
• Chapter 11 - The role of healthcare professionals
Appendix 1: Membership of the BMA Board of Science Reference Group
Appendix 2: The nature and addictiveness of commonly used illicit drugs
Appendix 3: Health-related harms of emerging and established licit and illicit drugs commonly used in the UK
Appendix 4: UK illicit drug usage data
Appendix 5: Overview of drug adulterants
Appendix 6: UK government strategies for reducing illicit drug use
Appendix 7: Societal measures to restrict drug influences
References
This publication contains a very useful glossary of terms.
A Substance use and dependence > Substance related societal (social) problems
B Substances > Opioids (opiates)
G Health and disease > State of health
G Health and disease > Substance use disorder (addiction) > Multiple substance use (Poly-drug /Poly-substance)
HJ Treatment or recovery method > Substance disorder treatment method
HJ Treatment or recovery method > Substance disorder treatment method > Substance disorder drug therapy (pharmacological treatment)
HJ Treatment or recovery method > Substance disorder treatment method > Substance replacement method (substitution)
HJ Treatment or recovery method > Substance disorder treatment method > Substance replacement method (substitution) > Opioid agonist treatment (methadone maintenance / buprenorphine)
HJ Treatment or recovery method > Psychosocial treatment method
J Health care, prevention, harm reduction and treatment > Risk and protective factors > Risk factors
J Health care, prevention, harm reduction and treatment > Harm reduction > Substance use harm reduction
J Health care, prevention, harm reduction and treatment > Substance use prevention > Universal prevention
J Health care, prevention, harm reduction and treatment > Substance use prevention > Targeted prevention
J Health care, prevention, harm reduction and treatment > Treatment and maintenance > Provider / worker / staff attitude toward treatment
J Health care, prevention, harm reduction and treatment > Health care delivery
J Health care, prevention, harm reduction and treatment > Health care programme, service or facility > Prison-based health service
J Health care, prevention, harm reduction and treatment > Health care programme, service or facility > Community-based treatment (primary care)
MP-MR Policy, planning, economics, work and social services > Policy > Policy on substance use
MP-MR Policy, planning, economics, work and social services > Policy > Policy on substance use > Harm reduction policy
MP-MR Policy, planning, economics, work and social services > Economic aspects of substance use (cost / pricing)
N Communication, information and education > Recommendations > Practice / clinical guidelines
T Demographic characteristics > Doctor / physician
VA Geographic area > Europe > United Kingdom
Repository Staff Only: item control page